Rigel Pharmaceuticals

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$69,462
$101,685
$53,333
$57,596
Gross Profit
64,709
97,181
48,924
51,807
EBITDA
30,117
62,463
13,968
17,781
EBIT
29,514
61,856
13,364
17,177
Net Income
27,900
59,613
11,446
14,341
Net Change In Cash
69,462
101,685
53,333
57,596
Free Cash Flow
24,019
30,537
-893
14,477
Cash
48,534
53,407
45,728
56,746
Basic Shares
19,156
18,162
18,169
17,986

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$179,278
$116,882
$120,242
$149,236
Gross Profit
160,631
109,772
118,493
148,153
EBITDA
28,512
-16,981
-53,868
-11,287
EBIT
26,284
-18,219
-54,866
-12,449
Net Income
17,485
-25,091
-58,573
-17,914
Net Change In Cash
179,278
116,882
120,242
149,236
Cost of Revenue
5,569
-11,483
Free Cash Flow
31,075
-20,743
-74,208
5,251
Cash
56,746
32,786
24,459
18,890
Basic Shares
17,687
17,401
17,240
17,049

Earnings Calls

QuarterEPS
2025-09-30
$1.46
2025-06-30
$3.28
2025-03-31
$0.63
2024-12-31
$0.80